Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
321695-57-2COc1ccc(S(=O)(=O)ON=C2C=C(C)C(=O)C(C)=C2)cc1VEWFTYOFWIXCIO-UHFFFAOYSA-N321695-57-2CHEMBL3775671Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
BeschreibungL002 is an inhibitor of p300 histone acetyltransferase (KAT3B; IC50 = 1.98 μM in vitro). It has weaker inhibitory effects against PCAF and GCN5 (IC50s = 35 and 34 μM, respectively) and is specific for p300 over a panel of additional acetyltransferases, deacetylases, and methyltransferases. L002 blocks acetylation of histones and p53 in cells treated with trichostatin A or etoposide, respectively, and reduces STAT3 phosphorylation, which requires p300-mediated acetylation of STAT3. It induces growth arrest and apoptosis in certain cancer cell lines and, when administered intraperitoneally in mice, suppresses the growth of triple-negative breast cancer xenografts.
VerwendenL002 is an inhibitor of p300 histone acetyl transferase, which maintains weaker inhibitory effects against PCAF and GCN5. and is specific for p3000.
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…